Public Health Ontario, Toronto, Ontario, Canada.
Euro Surveill. 2014 Jun 19;19(24):20831. doi: 10.2807/1560-7917.es2014.19.24.20831.
During the 2009 A(H1N1) influenza pandemic, a suite of studies conducted in Canada showed an unexpected finding, that patients with medically attended laboratory-confirmed pandemic influenza were more likely to have received seasonal influenza vaccination than test-negative control patients. Different bodies, including scientific journals and government scientific advisory committees, reviewed the evidence simultaneously to determine its scientific validity and implications. Decision-making was complicated when the findings made their way into the media. The normal trajectory of non-urgent research includes peer-review publication after which decision-makers can process the information taking into account other evidence and logistic considerations. In the situation that arose, however, the congruence of an unexpected finding and the simultaneous review of the evidence both within and outside the traditional peer-review sphere raised several interesting issues about how to deal with emerging evidence during a public health emergency. These events are used in this article to aid discussion of the complex interrelationship between researchers, public health decision-makers and scientific journals, the trade-offs between sharing information early and maintaining the peer-review quality assurance process, and to emphasise the need for critical reflection on the practical and ethical norms that govern the way in which research is evaluated, published and communicated in public health emergencies.
在 2009 年甲型 H1N1 流感大流行期间,加拿大开展了一系列研究,结果出人意料,与未检测出的对照患者相比,经医学诊断确诊患有大流行性流感的患者更有可能接种了季节性流感疫苗。包括科学期刊和政府科学顾问委员会在内的不同机构同时审查了证据,以确定其科学有效性和影响。当这些发现进入媒体时,决策变得复杂起来。非紧急研究的正常轨迹是在同行评审发表之后,决策者可以在考虑其他证据和后勤考虑的情况下处理信息。然而,在这种情况下,一个意外发现的一致性以及对传统同行评审领域内外证据的同时审查,引发了一些关于如何在公共卫生紧急情况下处理新出现证据的有趣问题。本文利用这些事件来帮助讨论研究人员、公共卫生决策者和科学期刊之间复杂的相互关系,以及尽早分享信息和维护同行评审质量保证过程之间的权衡取舍,并强调需要对在公共卫生紧急情况下评估、发表和传播研究的实践和伦理规范进行批判性反思。